ELC Enters Research Initiative with Breast Cancer Research Foundation

Estée Lauder Companies announced a five-year commitment to the Breast Cancer Research Foundation. Together, they will establish a Global Research Initiative on Breast Cancer in Younger Women. 

This first-of-its-kind research coalition will address the global rise in breast cancer diagnoses among younger women, building on over three decades of partnership between The Estée Lauder Companies and the Breast Cancer Research Foundation.

Estee Lauder committed $15 million from its Charitable Foundation. 

William P. Lauder, Chair, Board of Directors, The Estée Lauder Companies, and Co-Chair, the Breast Cancer Research Foundation, commented:

“The Estée Lauder Companies has a longstanding commitment to advancing breast cancer research, and I know my mother, Evelyn H. Lauder, would be so proud to see us carry her vision forward. She believed deeply in the power of research to change and ultimately save lives. Through this donation, we can expand our understanding of breast cancer in younger women, an area where there is still much to learn. I am grateful to the brilliant scientific researchers whose curiosity, dedication, and discoveries continue to bring us closer to our shared goal of a world free from breast cancer.”

The inaugural grant will launch the initial phase of research focused on the biology of breast cancer among younger women. 

It will examine the mechanisms that drive early-onset breast cancer, laying the foundation for accelerating the path from laboratory discovery to patient care.

By connecting scientists across countries, institutions, and disciplines, the initiative is designed to help break down traditional research silos, accelerate the exchange of knowledge, and establish a stronger scientific foundation for progress. 

Insights from its initial phase will help shape subsequent areas of investigation to translate discovery into meaningful advances for younger women facing breast cancer around the world.